Tag: valsarten

The Val-HeFT trial: Valsartan reduces morbidity in chronic heart failure [Classics Series]

byEvan Chenand1 others

April 12, 2014

Image: PD 1. Valsartan, an angiotensin-receptor blocker, significantly reduces morbidity, but not mortality, in heart failure patients when added to ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

An ultrasound test may more reliably detect ovarian cancer in premenopausal women than the Risk of Malignancy Index
Chimeric antigen receptor T-cell therapy may induce sustained remission in multirefractory autoimmune hemolytic anemia
Neonatal Hyperbilirubinemia and navigating the 2022 AAP guideline updates

No Result

View All Result